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both hypertensive diabetic group and hypertensive group was
signiﬁcantly decreased compared to that in the normal group
(P<0.05). While the mean plasma level of sVEGFR2 in hypertensive
diabetic group were signiﬁcantly decreased compared to the hyper-
tensive group (P<0.05). And the mean plasma level of visfatin in both
hypertensive diabetic group and only hypertensive group was
signiﬁcantly increased compared to that in the normal group
(P<0.05), and more increased in hypertensive diabetic patients.
(P<0.05). Moreover, there was a signiﬁcantly negative correla-
tion between sVEGFR2 and visfatin in the whole study population
(r¼ -0.497, P<0.01).
CONCLUSIONS Soluble VEGFR2 expression is decreased in both hy-
pertensive and hypertensive diabetic patients, and more decreased in
hypertensive diabetic patients. This study indicates that decreased
sVEGFR2 level may be associated with to the increase of visfatin.
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The prevalence and risk factors of postprandial hypotension in patients
with coronary heart disease
Yanan Zhang, Tianlei Chen, Wei Cui
Department of Cardiology, Second Hospital of Hebei Medical
University
OBJECTIVES The main feature of postprandial hypotension(PPH) is
the blood pressure being lower compared with that before a meal, and
it may lead to syncope, fall, dizziness, nausea, visual disturbance,
cardiovascular events, brain stroke and even death when it has a
sharply fall. This study focuses on patients with coronary heart dis-
ease to explore the prevalence of PPH among patients with coronary
heart disease and relevant risk factors.
METHODS Choose 289 patients with coronary heart disease, age
range: 24-90, average age: 62.0012.22 years old. All patients are
divided into different groups on the basis of age and different groups
by basic systolic blood pressure level. The blood pressure of patients
need to be measured before breakfast, lunch and dinner as well as 30,
60, 90 and 120min after meals.
RESULTS The systolic blood pressure of a total of 50 cases of 289
patients drops 20mmHg, and the prevalence of PPH is 17.30%. There
are 28 males (9.69%) and 22 females (7.61%) and the prevalence dif-
ference of PPH has no statistical signiﬁcance (P>0.05). The difference
of PPH among patients with diabetes, cerebrovascular disease, hy-
pertension, hyperlipemia has no statistical signiﬁcance (P>0.05).
Among patients with taking medications which affect the blood
pressure the prevalence is 15.57%; and the patients without taking
medications which affect the blood pressure have PPH along with
incidence is 1.73%; the difference of PPH has statistical signiﬁcance
(P<0.05). The prevalence of PPH for different age groups has no sta-
tistical signiﬁcance (P>0.05). The prevalence of PPH of breakfast,
lunch and dinner is 8.10%, 5.19% and 9.00%, the prevalence of
different mealtime has no statistical signiﬁcance (P>0.05). Taking
medications which affect the blood pressure and basic blood pressure
level are risk factors for PPH and corresponding OR is 4.05(95%CI 1.52-
10.79) and 1.84 (95%CI 1.37-2.49). But in the hospital, there is no
statistical difference in the adverse cardiovascular events between the
patients with PPH and other patients.
CONCLUSIONS The prevalence of PPH for patients with coronary
heart disease is 17.30%. There is no oblivious relevance between PPH
and gender, age, body position during meal and whether patients
have high blood pressure, hyperlipidemia, diabetes and cerebral
vascular disease. Taking medications which affect the blood pressure
and basic blood pressure level are risk factors for PPH.
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Renal sympathetic denervation for refractory hypertension after renal
artery stent placement
Yulin Chen,1,2 Qi Chen2
1The Afﬁliated Hospital of Hangzhou Normal University, Hangzhou,
China; 2Changhai Hospital, The Second Military Medical University,
Shanghai
OBJECTIVES Since renal sympathetic denervation (RDN) has been
recently shown to be an attractive new method in treating the patient
with resistant hypertension, we decided to proceed with RDN after
discussion with the patient.
METHODS The dosage of Iohexol contrast was 75 ml. The duration of
procedure was 55 minutes. The number of ablation point was 6 onboth sides. The left renal artery underwent ablation using routine
method.The duration of procedure was 55 minutes. The number of
ablation point was 6 on both sides. The left renal artery underwent
ablation using routine method.
RESULTS In this case report, we have successfully treated a patient
with resistant hypertension, who underwent renal artery stent
implantation.
CONCLUSIONS This is in accordance with previous reports that RDN
is well tolerated and a safe procedure. To best of our knowledge, there
are very few studies that RDN procedure was conducted in patient
who underwent renal artery stent implantation. Out ﬁnding suggest
that continued research into the RDN for the treatment of resistant
hypertension in selected patients is of interest.
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Effect of Irbesartan Combined with Diltiazem on Endothelium Dependent
Vasodilatation in Chinese Essential Hypertensives
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OBJECTIVES To investigate the effects of irbesartan combined with
diltiazem on the endothelium-dependent vasodilatation and cardio-
vascular protection in Chinese essential hypertensives.
METHODS 142Chinese hypertensives were enrolled in this study.
Hypertensive patients were divided into 3 groups: Irbesartan treated
(150 mg/day, n¼42), diltiazem treated (90 mg/day, n¼50), and com-
bined therapy ( Irbesartan 150 mg/dayþ diltiazem 90 mg/day, n¼50).
26 normotensives without cardiovascular risks served as control
group. Flow-mediated dilatation (FMD) induced by reactive hyper-
emia was used to determine endothelium-dependent dilatation (EDD)
and nitroglycerin-mediated dilatation (NMD) induced by nitroglycerin
was used to determine endothelium-independent dilatation (EID)
respectively in brachial arteries using high-resolution vascular ultra-
sound. Left ventricular mass index (LVMI) was evaluated by echo-
cardiography, Blood pressure (BP) and ﬁbrinogen (Fg) was monitored
at baseline and after treatment. All subjects were followed up for 1
year.
RESULTS BP, LVMI, Fg were higher and FMD and NMD were lower in
hypertensive patients than those in normotensive controls at base-
line. After 1- year treatment, there was a signiﬁcant increase of FMD in
combined therapy group compared with irbesartan treated group and
diltiazem treated group [(8.313.09)% vs (10.683.51)%, P<0.05], af-
ter stratiﬁcation of age, while there was no signiﬁcant difference in
NMD after therapy among three groups (P>0.05). FMD decreased
obviously with the increase of age, which turned out to be not so
obviously after irbesartan combined with diltiazem treatment
compared with normotensive controls. In addition, Fg decreased
signiﬁcantly after treatment in combined therapy group [(3.570.78)
g/L vs (3.090.83) g/L, P<0.05]. LVMI also reduced obviously after
irbesartan alone and combined therapy treatment and the reduction
of LVMI was much more remarkable in combined therapy group than
in irbesartan group [irbesartan group: (98.9318.23) g/m2 vs
(92.8214.48) g/m2, P<0.05; combined therapy group: (97.3216.93)
g/m2 vs (88.7016.21) g/m2, P<0.01].
CONCLUSIONS Irbesartan combined with diltiazem therapy could
improve the endothelium dependent vasodilatation in essential hy-
pertensives signiﬁcantly, regardless of age, further reduced LVMI and
Fg more obviously compared with monotherapy. Therefore, irbe-
sartan combined with diltiazem might be more beneﬁcial for reducing
the cardiovascular complications in hypertensives and presented su-
perior cardiovascular protection than monotherapy.
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Factors associated with morning blood pressure surge in young and
middle-aged essential hypertensive patients
Qian Wang, Yuanyuan Chen
Department of Heart Center, Peking University People’s Hospital
OBJECTIVES The study aimed to explore possible factors associated
with morning blood pressure surge, underlying pathophysiological
mechanisms and the target of drug therapy in young and middle–aged
essential hypertensive patients.
METHODS The objects included in this study were 160 young and
middle–aged (younger than 60 years) essential hypertensive patients
who were in the ward of hypertension in Peking University People’s
Hospital from November 1,2011 to January 31,2015. All the objects
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recently four weeks. All the patients provided detailed information of
history of illness, received carefully physical and laboratory exami-
nations and were performed ambulatory blood pressure monitoring
(ABPM) and ambulatory electrocardiogram (ECG) recording mean-
while. We collected carotid ultrasonography, brachial-to-ankle pulse
wave velocity (ba–PWV) and ankle brachial index (ABI) from most
of these patients. All patients were divided into the MBPS group,
which was deﬁned as having the highest quartile of morning BP
increase from sleep (28.67mmHg; n ¼ 44) and the non-MBPS
group(<28.67mmHg; n ¼ 116). And then we compared all indexes
between these two groups.
RESULTS MBPS was correlated positively with day–night systolic
blood pressure (SBP) dipping (r ¼ 0.5, p<0.001).And the circadian
blood pressure pattern was mostly dipper in MBPS group, while non-
dipper in non–MBPS group. Compared with patients in non–MBPS
group, those in MBPS group had higher 24 hours systolic blood pres-
sure variability (24h–SBP–BPV), 24 hours diastolic blood pressure
variability (24h–DBP–BPV), nighttime systolic blood pressure vari-
ability (N–SBP–BPV) and nighttime diastolic variability (N–DBP–BPV).
And their correlation coefﬁcients with MBPS were 0.325,0.315,0.316
and 0.286 respectively (p <0.001). After adjustments for factors
associated with MBPS these correlations still existed signiﬁcantly,
except for N–DBP–BPV. The morning heart rate surge (MHRS), the
24 hours mean systolic blood pressure (24 h–SBP) proﬁle and daytime
mean diastolic blood pressure (D–SBP) proﬁle were higher in the MBPS
group than in the non–MBPS group (MHRS: 15.81  6.86 bpm versus
13.22  7.11 bpm, p<0.05; 24h–SBP: 136.41  16.32 mmHg versus 130.41
 15.93 mmHg, p<0.05; D–SBP:140.52  16.44 mmHg versus 131.76 
17.34 mmHg, p <0.05 ) and they all had no linear correlations with
MBPS.
CONCLUSIONS In young and middle-aged essential hypertensive
patients, the day-night SBP dipping, 24h–BPV and N–BPV may be
important factors associated with MBPS. Compared with DBP–BPV,
SBP–BPV has greater inﬂuence on MBPS. 24h–BPV also has more in-
ﬂuence on MBPS than N–BPV. Meanwhile, we also ﬁnd that MHRS is
related to MBPS. Therefore, we speculate that in these young and
middle–aged essential hypertensive patients, sympathetic nervous
system activation may be the main mechanism underlying MBPS.
Moreover, 24h–SBP and D–SBP also have an effect on MBPS to some
extent.GW26-e2487
Clinical Analysis of Primary Aldosteronism with Hypertension
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OBJECTIVES To evaluate the clinical characteristics of primary aldo-
steronism (PA) with hypertension.
METHODS From 2002 to 2015, 56 patients with PA were diagnosed
according 2008 American endocrine society clinical practice guideline
about PA. Clinical proﬁles and fasting serum sodium, potassium,
aldosterone level, plasma rennin activity, angiotensin level, aldoste-
rone-to-rennin activity ratio(ARR), cystatin C(CysC) and b2-micro-
globulin (b2-M) were recorded and analyzed.
RESULTS Of these patients, age of diagnosis was (48.912.4) years,
62.5% were male, 69.6% were aldosteronoma, 30.4% were idiopathic
aldosteronism. Course of hypertension was (5.365.24) years, in
which 27.8% were less than 1 year, 33.3% were 1-5 years, 29.6% were 5-
10 years, 9.3% were over 10 years. The prevalence of 1, 2, and 3 stage
hypertension in these patients was 61.1%, 29.6%, and 9.3%, respec-
tively. It was found that systolic blood pressure (166.520.4) mmHg,
diastolic blood pressure (94.316.7) mmHg, PRA(0.300.29) ng/ml/h,
aldosterone level(26.117.3) ng/dl, angiotensin II level (115.5103.9)
pg/ml, ARR (107.17(45.28, 560.17)). The incidence of hypokalemia,
hypernatremia and arteriosclerosis was 64.8%, 20.4%, 39.3%,
respectively. Correlation analysis showed that the course of PA was
positively correlated with CysC, b2-M, serum sodium (r¼0.348,
r¼0.453, r¼0.401, P<0.05), negatively correlated with serum potas-
sium (r¼ - 0.277, P<0.05). It was also shown that diastolic blood
pressure was positively correlated with aldosterone level (r¼ 0.282,
P<0.05).
CONCLUSIONS Primary aldosteronism with hypertension was more
likely to happen in middle-aged men due to aldosteronoma,manifested as mild to moderate hypertension, with relatively long
course before diagnosis which may affect several related factors.
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A study of relation between plasmic Brain Natriuretic Peptide
and Essential Hypertension (EH) Target-organ Damage
Ping Yang, Xiaohua Dong, Qingyuan Dai, Qixian Wang
Department of Cardiology, The ﬁrst afﬁliated Hospital of Kunming
Medical University
OBJECTIVES To investigate the association between plasmic Brain
Natriuretic Peptide (BNP) and essential hypertension (EH) Target-
organ Damage (TOD).
METHODS We studied 83 never-treated patients with essential
hypertension and 20 normal subjects. Hypertensive patients were
divided into two groups. one group was 68 patients with target-organ
damage and the other was 15 patients without target-organ dam-
age(pure hypertensive patients). Then 68 patients with TOD were
subdivide into subgroups: with 30 left ventricular hypertrophy(LVH),
10 carotid artery wall thickening, 10 renal damage and 18 stroke. All
subjects received general situation, blood pressure, fasting plasma
glucose and blood lipid levels, liver function, renal function, urinary
albumin, a standard 12-lead ECG, 24-hour blood pressure, echocardi-
ography, carotid ultrasonography and cerebral CT or MRI so on. The
plasmic BNP quantity were measured by Enzyme-linked immuno-
sorbent assay(ELISA).
RESULTS 1.The plasma level of BNP was elevated in the essential
hypertension(EH) group than normal subjects(P<0.05). 2.essential
hypertension with target organ damage in each subgroup of plasma
BNP levels were higher than in pure essential hypertension group and
normal control group, the differences were statistically signiﬁcant
(P<0.05). And the plasma BNP level comparison among various sub-
groups of essential hypertension with target organ damage, there
were no statistically signiﬁcant difference (P>0.05). 3.In patients with
LVH correlation analysis showed that: The plasma level of BNP took
positive correlation with left ventricular mass index(LVMI) (r¼0.693,
P<0.01), took inverse correlation with LVEF(r¼-0.768, P<0.01).
CONCLUSIONS These results indicate that BNP is related to the oc-
currences and developments of essential hypertension and target-
organ damage, may become a no-traumatic laboratory indicator in the
process of essential hypertension diagnosis and treatment. It has a
positive meaning in the disease of changes and prognosis assessment
to guide clinical treatment through measuring BNP levels in patients
with hypertension and target-organ damage.
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Efﬁcacy of different doses atorvastatin on the blood pressure:
a Meta-analysis
Huanhuan Zhao, Yuemin Sun
Tianjin Medical University General Hospital
OBJECTIVES Although the effects of statins on blood pressure has
been conﬁrmed, the efﬁcacy of different dose atorvastatin on blood
pressure remains controversial. Our meta-analysis was performed of
different dose atorvastatin on blood pressure in humans including the
randomized, controlled trials of atorvastatin therapy.
METHODS We collected data from twenty-seven randomized control
trials of atorvastatin that had the blood pressure reported as one of
the endpoints. Weighted Mean Difference(WMD) was used as a mea-
sure of the effect of atorvastatin on blood pressure.The analysis was
further stratiﬁed by factors that could affect the treatment effect.
RESULTS We found that systolic blood pressure (SBP) in the ator-
vastatin group decreased by 3.14 mmHg (95% conﬁdence interval
[CI]:2.13 to 4.15 mmHg) and diastolic blood pressure (DBP) by
1.35 mmHg (95% CI: 0.78 to 1.92 mmHg). In 10mg atorvastatin groups,
SBP decreased by 1.17 mmHg (95% CI: 0.22 to 2.13 mmHg), but DBP had
no change (DBP: 0.17 mmHg; 95% CI:-0.64 to 0.98 mmHg). In 20mg
atorvastatin groups, SBP decreased by 5.82 mmHg (95% CI: 2.32 to
9.32 mmHg) and DBP by 2.93 mmHg (95% CI: 1.11 to 4.75 mmHg). In
40mg atorvastatin groups, SBP decreased by 3.58 mmHg (95% CI: 0.10
to 7.06 mmHg) and DBP by 2.76 mmHg (95% CI: 0.38 to 5.14 mmHg). In
80mg atorvastatin groups, SBP decreased by 2.98 mmHg (95% CI: 2.12
to 3.84 mmHg), but DBP had no changes (DBP: 0.24 mmHg, 95% CI:
-2.72 to 3.20 mmHg).
CONCLUSIONS Our ﬁndings indicated that different dose atorvasta-
tin therapy has a relatively small but statistically signiﬁcant and
clinically meaningful effect on blood pressure.
